Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNYNF) Return on Sales (2016 - 2025)

Historic Return on Sales for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to 0.33%.

  • Sanofi's Return on Sales rose 3600.0% to 0.33% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.07% for FY2025, which is 700.0% up from last year.
  • Latest data reveals that Sanofi reported Return on Sales of 0.33% as of Q4 2025, which was up 3600.0% from 0.09% recorded in Q3 2025.
  • Sanofi's 5-year Return on Sales high stood at 1.12% for Q4 2022, and its period low was 0.03% during Q4 2024.
  • In the last 5 years, Sanofi's Return on Sales had a median value of 0.19% in 2021 and averaged 0.21%.
  • As far as peak fluctuations go, Sanofi's Return on Sales plummeted by -11300bps in 2021, and later surged by 10900bps in 2022.
  • Over the past 5 years, Sanofi's Return on Sales (Quarter) stood at 0.03% in 2021, then skyrocketed by 4315bps to 1.12% in 2022, then tumbled by -101bps to 0.01% in 2023, then tumbled by -171bps to 0.03% in 2024, then skyrocketed by 1307bps to 0.33% in 2025.
  • Its Return on Sales stands at 0.33% for Q4 2025, versus 0.09% for Q3 2025 and 0.14% for Q2 2025.